glp-1 rheumatoid arthritis GLP-1s for diabetes reduce arthritis, gout risk Treating Rheumatoid Arthritis with GLP-1
Description
Requests that pose a potential conflict of interest or an actual or potential competitive risk may be declined at Amgens sole discretion and without further arbitration
Historically, oncology and immunology were the primary targets for pharmaceutical companies, with most resources and capital allocated to developing new technologies in these areas
Media Contact: [email protected] SOURCE Ro
Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, et al
